Co-Diagnostics Receives Notice Of Allowance For U.S. Patent Covering Nucleic Acid Analysis Methods
https://patentcenter.uspto.gov/applications/18146051/ifw/docs
Last updated: 2026-11-19 04:00:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Co-Diagnostics, Inc. (CODX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.20, with a market capitalization of $2.36M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.17 to $13.54. This page covers its latest market performance, valuation, price trends and company information.
$2.36M | |
$0.20 | |
$0.22 | |
$0.19 | |
$0.20 | |
1.06M | |
2.00M | |
-- | |
$13.54 | |
$0.17 | |
-- | |
2026-09-30 |
Co-Diagnostics, Inc. (CODX) last closed at $0.20 as of 2026-11-19 01:00:00, up 1.12% ($0.00) from the previous close of $0.20.
During the latest regular trading session, CODX traded between $0.19 and $0.22, with a volume of 1.06M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Co-Diagnostics, Inc. (CODX) moved from $0.32 to $0.20, representing a decline of 38.24% ($0.12).
The stock traded between $0.17 and $0.34 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 15.20 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.2%
CODX is currently trading at $0.20, placing it 0.2% of the way from its 52-week low of $0.17 to its 52-week high of $13.54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 115 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to Co-Diagnostics, Inc. and CODX stock.
https://patentcenter.uspto.gov/applications/18146051/ifw/docs
Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) shares rose 169.8% to $20.16 during Tuesday's regular session. The market value of their outstanding shares is at $1.5 billion. As per the press release, Q3 earnings
Gainers Addex Therapeutics (NASDAQ:ADXN) stock rose 74.0% to $5.03 during Thursday's pre-market session. ZeroStack (NASDAQ:ZSTK) stock increased by 11.56% to $2.99. The market value of their outstanding shares is
Eligible investors can buy real shares of Co-Diagnostics, Inc. (CODX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CODX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CODX shares and USD.
CODX Shares to USD
1.00 CODX shares = 0.197 USD
Calculations are estimates based on the latest available price and are for reference only.